IDENTIFYING BIOMARKERS AND DISSECTING COMBINATORIAL SYNERGIES TO IMPROVE IMMUNE CHECKPOINT INHIBITOR RESPONSE IN BLADDER CANCER
$623,580FY2020Defense Health AgencyDOD
The Cleveland Clinic Foundation
Investigators
View source on USAspending →IDENTIFYING BIOMARKERS AND DISSECTING COMBINATORIAL SYNERGIES TO IMPROVE IMMUNE CHECKPOINT INHIBITOR RESPONSE IN BLADDER CANCER · GrantIndex